| GTO ID | GTC2266 |
| Trial ID | NCT04191941 |
| Disease | Multiple Myeloma | B-Cell Acute Lymphoblastic Leukemia | B-Cell Non-Hodgkin's Lymphoma |
| Therapy | CAR-T cell |
| Treatment | Novel CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Treatment of Hematological Malignancy With Novel CAR-T Cells. |
| Year | 2019 |
| Country | China |
| Company sponsor | Timmune Biotech Inc. |
| Other ID(s) | 2019-24.1 |
| Cohort 1 | |||||||||
|
|||||||||